Sanjiv.Parant.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE860D01013
  • NSEID:
  • BSEID: 531569
INR
146.00
-9.7 (-6.23%)
BSENSE

Mar 23

BSE+NSE Vol: 21.84 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Quest Laborato.
Syschem (India)
Sanjiv.Parant.
Ambalal Sarabhai
Transchem
Oxygenta Pharma
Aarey Drugs
Kerala Ayurveda
Nectar Lifesci.
Lyka Labs
Aptus Pharma

Why is Sanjivani Paranteral Ltd ?

1
High Management Efficiency with a high ROE of 16.64%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.86 times
3
Healthy long term growth as Operating profit has grown by an annual rate 62.32%
4
Positive results in Dec 25
  • NET SALES(Q) At Rs 22.06 cr has Grown at 28.0% (vs previous 4Q average)
  • PBDIT(Q) Highest at Rs 3.84 cr.
  • OPERATING PROFIT TO NET SALES(Q) Highest at 17.41%
5
With ROCE of 17.6, it has a Attractive valuation with a 3.5 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -44.91%, its profits have risen by 14.1% ; the PEG ratio of the company is 2.5
6
Majority shareholders : Non Institution
7
Underperformed the market in the last 1 year
  • Even though the market (BSE500) generated negative returns of -3.31% in the last 1 year, its fall in the stock was much higher with a return of -44.91%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Sanjiv.Parant. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Sanjiv.Parant. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Sanjiv.Parant.
-44.91%
-0.86
52.51%
Sensex
-5.47%
-0.43
12.65%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
27.21%
EBIT Growth (5y)
62.32%
EBIT to Interest (avg)
9.92
Debt to EBITDA (avg)
1.89
Net Debt to Equity (avg)
0.19
Sales to Capital Employed (avg)
-1.49
Tax Ratio
23.15%
Dividend Payout Ratio
7.33%
Pledged Shares
0
Institutional Holding
6.04%
ROCE (avg)
-6.02%
ROE (avg)
16.64%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
22
Industry P/E
32
Price to Book Value
4.00
EV to EBIT
17.73
EV to EBITDA
16.58
EV to Capital Employed
3.52
EV to Sales
2.55
PEG Ratio
2.53
Dividend Yield
0.34%
ROCE (Latest)
17.55%
ROE (Latest)
16.64%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company
NET SALES(Q)

At Rs 22.06 cr has Grown at 28.0% (vs previous 4Q average

PBDIT(Q)

Highest at Rs 3.84 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 17.41%

PBT LESS OI(Q)

Highest at Rs 3.40 cr.

PAT(Q)

Highest at Rs 2.78 cr.

EPS(Q)

Highest at Rs 2.26

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...

Here's what is working for Sanjiv.Parant.

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 3.40 cr has Grown at 56.1% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 2.18 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 2.78 cr has Grown at 49.1% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 1.87 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 22.06 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 22.06 cr has Grown at 28.0% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 17.23 Cr
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 3.84 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 17.41%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 3.40 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 2.78 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 2.26
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)